固力康联合鲑鱼降钙素治疗老年性骨质疏松的临床疗效及安全性

The efficacy and safety of Menatetrenone Soft Capsules combined with Salmon calcitonin in the treatment of elderly osteoporosis

目的对固力康联合鲑鱼降钙素治疗老年性骨质疏松的临床疗效及安全性进行分析。方法选取2014年9月至2016年1月于我院治疗的122例老年性骨质疏松患者进行研究,按照患者入院时间进行分成两组,治疗组、对照组分别61例,给予对照组患者鲑鱼降钙素进行治疗,治疗组患者给予固力康联合鲑鱼降钙素进行治疗,在治疗6月后,将两组患者的疼痛VAS评分、腰椎及髋部骨密度、骨钙素(BGP)和β-胶原降解产物(β-Cross Laps)变化情况进行对比,同时对患者服药后的不良反应发生率进行比较。结果治疗6个月后两组患者VAS评分均较治疗前有明显改善(P<0.05),且治疗组患者评分明显低于对照组(P<0.05)。治疗6个月后,两组患者骨密度较治疗前都显著改善(P<0.05),血清BGP和β-Cross Laps较治疗前有显著改变(P<0.05),且均明显优于对照组(P<0.05)。两组药品不良反应发生率比较,差异无统计学意义(P>0.05)。结论固力康联合鲑鱼降钙素治疗老年性骨质疏松效果显著,安全性较高,值得在临床中推广应用。

Objective To examine the clinical efficacy and safety of Menatetrenone Soft Capsules combined with Salmon calcitonin in the treatment of elderly osteoporosis. Methods The study was conducted in 122 cases of senile osteoporosis who were selected from patients attending clinics of our hospital from September 2014 to January 2016. Patients were grouped according to hospitalization time,with 61 patients in each group. Patients in the control group were given Salmon calcitonin,and patients in the treatment group received combined Menatetrenone Soft Capsules and Salmon calcitonin treatment. After 6 months of treatment,comparisons were made between the two groups on the changes in pain VAS score,bone mineral density,Osteocalcin（ BGP） and beta-collagen degradation products（ β-Cross Laps）,and the incidence of adverse reactions. Results The VAS scores of patients in both groups 6 months after the treatment were all improved compared with before treatment（ P 〈 0. 05）,and the scores of patients in the treatment group were significantly lower than those in the control group（ P 〈 0. 05）. After 6 months of treatment,BMD of both groups significantly improved（ P 〈 0. 05）. Serum BGP and β-Cross Laps changed significantly compared with before treatment（ P 〈0. 05）,and all index were better than those of the control group（ P 〈 0. 05）. When comparing the incidence of adverse drug reaction between the two groups,the difference had no statistical significance（ P 〉 0. 05）. Conclusion The combination of Menatetrenone Soft Capsules with Salmon calcitonin in the treatment of elderly osteoporosis is effective and safe,and suitable for wider clinical application.